Key result
Human fetal aortic CD133+ progenitor cells accelerate ischemic diabetic wound healing via paracrine signaling.
Answers are grounded in this paper and cite their sources.
Demonstrates that CD133+ progenitor cells and their secretome accelerate diabetic ulcer healing in ischemic mice via Wnt signaling, suggesting novel cell-free regenerative therapies.
We evaluated the healing potential of human fetal aorta-derived CD133(+) progenitor cells and their conditioned medium (CD133(+) CCM) in a new model of ischemic diabetic ulcer. Streptozotocin-induced diabetic mice underwent bilateral limb ischemia and wounding. One wound was covered with collagen containing 2x10(4) CD133(+) or CD133(-) cells or vehicle. The contralateral wound, covered with only collagen, served as control. Fetal CD133(+) cells expressed high levels of wingless (Wnt) genes, which were downregulated following differentiation into CD133(-) cells along with upregulation of Wnt antagonists secreted frizzled-related protein (sFRP)-1, -3, and -4. CD133(+) cells accelerated wound closure as compared with CD133(-) or vehicle and promoted angiogenesis through stimulation of endothelial cell proliferation, migration, and survival by paracrine effects. CD133(+) cells secreted high levels of vascular endothelial growth factor (VEGF)-A and interleukin (IL)-8. Consistently, CD133(+) CCM accelerated wound closure and reparative angiogenesis, with this action abrogated by co-administering the Wnt antagonist sFRP-1 or neutralizing antibodies against VEGF-A or IL-8. In vitro, these effects were recapitulated following exposure of high-glucose-primed human umbilical vein endothelial cells to CD133(+) CCM, resulting in stimulation of migration, angiogenesis-like network formation and induction of Wnt expression. The promigratory and proangiogenic effect of CD133(+) CCM was blunted by sFRP-1, as well as antibodies against VEGF-A or IL-8. CD133(+) cells stimulate wound healing by paracrine mechanisms that activate Wnt signaling pathway in recipients. These preclinical findings open new perspectives for the cure of diabetic ulcers.
No takes yet. Share an insight, caveat, or question.
Barcelos et al. (2009) studied Ischemic diabetic ulcer. Human fetal aorta-derived CD133+ progenitor cells and their conditioned medium (CD133+ CCM) vs. CD133- cells, vehicle, or collagen-only contralateral wound was evaluated on Wound closure and reparative angiogenesis. Human fetal aorta-derived CD133+ progenitor cells (2x10^4) and their conditioned medium accelerated ischemic diabetic wound closure and angiogenesis via paracrine VEGF-A, IL-8, and Wnt signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: